Ocugen
Pushpendra Singh currently serves as Senior Director and Head of Product Development at Ocugen, a position held since November 2019, and has previously worked in various roles including Director and Associate Director in Cell and Gene Therapy. Prior to Ocugen, Pushpendra Singh was a Postdoctoral Research Scientist at The Henry M. Jackson Foundation for the Advancement of Military Medicine, focusing on vaccine development for HIV and other infectious diseases. Additional experience includes a Postdoctoral Research Associate position at Johns Hopkins Medicine International and a Postdoctoral Associate role at Stowers Institute for Medical Research. Pushpendra Singh holds a Master’s Degree in Biotechnology from Jawaharlal Nehru University, earned between 2003 and 2005.
This person is not in any teams
This person is not in any offices
Ocugen
1 followers
Ocugen Inc. (NASDAQ: OCGN) is a biopharmaceutical company focused on discovering, developing, and commercializing gene therapies to cure blindness diseases and developing a vaccine to fight COVID-19.